secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001558370-25-006844
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q1 adj EPS $0.23, revenue $2.63B; reaffirms FY guide, active on P&HS sale
--------------------------------------------------------------------------------

- Adjusted EPS $0.23 vs $0.19 YoY; GAAP net loss $(0.32) per share vs $(0.29).
- Revenue $2.63B (+0.7% YoY); Patient Direct segment margin +173 bps.
- Adjusted EBITDA $121.9M vs $116.3M YoY; full-year 2025 guidance reaffirmed.
- Company actively engaged in potential sale of Products & Healthcare Services segment.
- Integrating planned Rotech acquisition; monitoring tariff policy impacts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000155837025006844/0001558370-25-006844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000155837025006844/omi-20250508x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-006844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer